Summary
Injectable soft tissue fillers play an important role in the aesthetic treatment of the ageing face. Staving off wrinkles and folds accounts for the most popular minimally invasive procedures performed.
Since the acceptance of collagen as a filler in 1977, new reabsorbable and non-reabsorbable implants have appeared with varying degrees of success. Most of the early dermal-filling materials, of historical interest, were potentially long lasting, even permanent. Today, as we know more about products and their potential complications, a more accurate treatment plan can be arranged for the patient.
The ideal desired characteristics for a soft tissue filler are that they must be safe, biocompatible, easy to inject, readily prepared, easy to store, affordable, have long lasting cosmetic effect, and not provoke any complications. In this chapter, we go through the history of dermal-filling materials, mentioning the most important biodegradable, semipermanent, and nonbiode-gradable fillers. Technical guidelines are given. The conclusion is that today injectable fillers based on hyaluronic acid hold many of the sought-after properties of the ideal filler and please patients' demand for products with little associated risk. Nonbiodegradable fillers can give a definitive correction but involve the risk of severe and permanent adverse reactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alster TS, West TB. New options for soft tissue augmentation. Skin Aging. 1998;6:32â36.
Ahn MS. Calcium hydroxyapatite: Radiesse. Facial Plast Surg Clin North Am. 2007:15(1):85â90, vii. Review.
Balazs EA, Leshchiner EA. Hyaluronan, its cross linked derivative-hylan and their medical applications. In: Inagaki H, Philips GO eds. Cellulosics Utilisation: Research and Rewards in Cellulosics. New York: Elsevier Applied Science; 2000:233â241.
Benedetto AV, Lewis AT. Injecting 1000 centistoke liquid silicone with ease and precision. Dermatol Surg. 2003;29: 211â 214.
Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthetic Surg J. 2004;24:33â46.
Born T, Airan LE, McGrath MH, Hughes CE III, Nahai F. Soft tissue fillers in aesthetic facial surgery. In: Nahai F ed. The Art of Aesthetic Surgery, Vo l I. St. Louis, MO: Quality Medical Publishing; 2005:224â288.
Born T. Hyaluronic acids. Clinics in Plastic Surgery. 2006; 33(4): 525â 538.
Broder KW, Cohen SR. An overview of permanent and semi-permanent fillers. Plast. Reconstr. Surg. 2006; 118:7â14.
Bui P, Pons-Guiraud A, Kuffer R, Plantier F, Nicolau P. Les produits injectables lentement et non rĂ©sorbables. Ann Chir Plast. 2004;49:486â502.
CharriĂšre G, Bejot M, Schnitzler L, Ville G, Hartmann DJ. Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. J Am Acad Dermatol. 1989;21:1203â1208.
Clark DP, Hanke CW, Swanson NA. Dermal implants: safety of products injected for tissue augmentation. J Am Acad Dermatol. 1989;21:992â998.
Cohen SR, Berner C F, Busso M, et al. ArteFill: a long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4 to 5-years outcomes. Plast Reconstr Surg. 2006;118:64â76.
Dijkema S, Van der Lei B, Kibbelaar RE. New-fill injections may induce late-onset foreign body granulomatous reaction. Plast Reconstr Surg. 2005;115:76â78.
Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Onc. 1989; 15:301â303.
Engelhard P, Humble G, Mest D. Safety of sculptra: a review of clinical trial data. J Cosmet Laser Ther. 2005;7:201â205.
Faure M. Complication des implants de silicone et autres matĂ©riaux dits inertes. Ann Dermatol VĂ©nĂ©rĂ©ol. 1995; 122:455â459.
Fagien S, Stuzin J. Injectable soft-tissue augmentation: The present and the future. Plast Reconstr Surg. 2007;120:5â7.
Fagien S, Klein AW. A brief overview and history of temporary fillers: evolution, advantages, and limitations. Plast Reconstr Surg. 2007;120(6 Suppl):8Sâ16S.
Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with zyderm or zyplast collagen implant. J Am Acad Dermatol. 1991;25:319â326.
Klein AW. Injectable collagen gives good cosmetic results in soft-tissue augmentation. Cosmetol Dermatol. 1992;5:42â43.
Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft tissue augmentation. Plast Reconstr Surg. 1977;60: 396â405.
Lambros V. Hyaluroniuc acid injections for correction of tear trough deformity. Plast Reconstr Surg. 2007;120 (6 Suppl):74Sâ80S.
Larsen NE, Pollak CT, Reiner K, Leshchiner E, Balazs EA. Hylan gel biomaterial: dermal and immunologic compatibility. Biomed Mat Res. 1993;27:1129â1134.
Lemperle G, Ott H, Charrier U, Hecker J, Lemperle M. PMMA microspheres for intradermal implantation: part 1. Animal research. Ann Plast Surg. 1991;26:7â63.
Lemperle G, Morhenn V, Charrier U. (2003) Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003;5:354â66.
Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29:573â587.
Lemperle G, de Fazio, Nicalou P. Artefill: a third generation permanent dermal filler and tissue stimulator. In: Jansen DA ed. Current Trends in Facial Fillers, Clinics in Plastic Surgery. 2006;33(4):551â566.
Maas CS, Papel ID, Greene D, Stoker DA. Complications of injectable synthetic polymers in facial augmentation. Dermatol Surg. 1997;23:871â877.
Matarasso S. Injectable collagens: lost but not forgottenâa review of products, indications, and injection techniques. Plast Reconstr Surg. 2007;120(6 Suppl):17Sâ26S.
Micheels P. Human anti-hyaluronic acid antibodies: is it possible. Dermatol Surg. 2001;27:185â191.
Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinckles and folds. Aesthet Plast Surg. 1998;22:97â101.
Pearl RM, Laub DR, Kaplan EN. Complications following silicone injections for augmentation of the contour of the face. Plast Reconstr Surg. 1978;61:888â891.
Pfulg M, Micheels P. Produits injectables: des effets secondaires Ă ne plus savoir qu'en faire. Revue trimestrielle de l'AFME. 1998;6:6â10.
Piaquadio D. L'acide hyaluronique rĂ©ticulĂ© (Hylan Gel) utilisĂ© comme produit d'augmentation des tissus mous: estimation prĂ©liminaire. J MĂ©d Esth Chir Dermatol. 1996;23:223â226.
Pons-Guiraud A. RĂ©actions d'hypersensibilitĂ© retardĂ©e aux implants de collagĂšne bovin. Ătudes sur 810 patients. Nouv Dermatol. 1992;11:422â432.
Pons-Guiraud A. Actualisation des effets secondaires des produits de comblement des rides. Nouv Dermatol. 2003;22:202â204.
Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulitis, ulceration, and migration. Aesthet Plast Surg. 1996;20:267â276.
Rohrich R, Ghavami A, Crosby M. The role of hyaluronic acid fillers (restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg. 2007;120(6 Suppl):41Sâ54S. Review.
Rostan E. Collagen fillers. Facial Plast Surg Clin North Am. 2007;15(1):55â61, vi. Review.
Rudolph CM, Soyer P, Schuller-Petrovic S, Kerl H. Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol. 1999;23:113â117.
Rzany B, Zielke H. Overview of injectable fillers. In: De Maio M and Rzany B ed. Injectable Fillers in Aesthetic Medicine. Berlin-Heidelberg: Springer Verlag; 2006:1â9.
Saylan Z. Facial fillers and their complications. Aesthetic Surg J. 2003;23:221â224.
Sherman RN. Sculptra: the new three-dimensional filler. In: Jansen DA ed. Clin Plast Surg.2006;33(4):539â50.
Splenlehauer G, Vert M, Benoit JP, Boddaert A. Injectables non-résorbables pour le traitement des rides. Swissmedic Journal 2003;2:94.
Injectables non-résorbables pour le traitement des rides. Swissmedic Journal 2003;2:94.
Valantin MA, Aubron O, Ghosn J. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003;17:2471â2477.
Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-L-lactic acid). J. Drugs Dermatol. 2004;5:42â47.
Von Buelow S, von Heimburg D, Pallua N, Cohen SR. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation. Plast Reconstr Surg. 2005;116: 1137â1146.
Webster RC, Gaunt JM, Hamdan US, Fuleihan NS, Smith RC. Injectable silicone for facial soft-tissue augmentation. Arch Otolaryngol Head Neck Surg. 1986;112:290â926.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this chapter
Cite this chapter
Pfulg, M.E., LĂȘ-Huu, S. (2010). Esthetic Skin Treatments (Fillers). In: Siemionow, M.Z., Eisenmann-Klein, M. (eds) Plastic and Reconstructive Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/978-1-84882-513-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-84882-513-0_17
Publisher Name: Springer, London
Print ISBN: 978-1-84882-512-3
Online ISBN: 978-1-84882-513-0
eBook Packages: MedicineMedicine (R0)